Actively Recruiting
Evaluating the Safety and Effectiveness of the RENATUS4 Transcatheter Aortic Valve System for Treating Severe Aortic Valve Narrowing in Adults Aged 60 to 100
Led by Beijing Balance Medical Technology Co., Ltd · Updated on 2026-02-17
800
Participants Needed
4
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the RENATUS4 Transcatheter Aortic Valve System for treating severe aortic stenosis, a serious heart valve condition. This is a prospective, non-randomized, observational follow-up study conducted after the device has been marketed. The study aims to gather important information about patients with severe aortic stenosis who undergo this treatment, including those at various surgical risk levels. Participants will receive the RENATUS4 Transcatheter Aortic Valve System as the main treatment during the study. The trial does not include randomization or comparison groups, focusing instead on monitoring patients who receive this device. It will track outcomes over time, including procedural and device success rates during the operation and mortality rates at various points after the procedure. Participants will be followed for up to 10 years after receiving the valve replacement. Researchers will assess safety by recording all-cause mortality at 1, 3, 5, and 10 years post-procedure. They will also monitor procedural success and device performance shortly after the operation. Patients will undergo required examinations and clinical follow-up visits to collect data throughout the study duration, which extends until September 2037.
CONDITIONS
Brief Title
Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
Research Team
L
Lai Yongqiang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here